Teladoc Health, Inc. (NYSE:TDOC) Q3 2023 Earnings Conference Call October 24, 2023 4:30 PM ET

Company Participants

Patrick Feeley - Head of Investor Relations

Jason Gorevic - Chief Executive Officer

Mala Murthy - Chief Financial Officer

Conference Call Participants

Lisa Gill - JPMorgan

Ryan Daniels - William Blair

Jailendra Singh - Truist

Richard Close - Canaccord Genuity

Lucas Romanski - TD Cowen

George Hill - Deutsche Bank

Jessica Tassan - Piper Sandler

Daniel Grosslight - Citi

Elizabeth Anderson - Evercore ISI

Sean Dodge - RBC Capital

Operator

Good afternoon. Thank you for attending the Teladoc Health Third Quarter Earnings Call. My name is Matt, and I'll be your moderator for today's call. All lines will be muted during the presentation portion of the call for an opportunity for questions and answers at the end. [Operator Instructions]

I'd now like to pass the conference over to our host, Patrick Feeley, Head of Investor Relations. Patrick, please go ahead.

Patrick Feeley

Thank you and good afternoon. Today, after the market closed, we issued a press release announcing our third quarter 2023 financial results. This press release and the accompanying slide presentation are available on the Investor Relations section of the teladochealth.com website.

On this call to discuss the results are Jason Gorevic, Chief Executive Officer; and Mala Murthy, Chief Financial Officer. During this call, we will also discuss our fourth quarter and full year 2023 outlook and our prepared remarks will be followed by a question-and-answer session.

Please note that we will be discussing certain non-GAAP financial measures that we believe are important in evaluating Teladoc Health's performance. Details on the relationship between these non-GAAP measures to the most comparable GAAP measures and reconciliations thereof can be found in the press release that is posted on our website.

Also please note that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995 such forward-looking statements are subject to risks, uncertainties, and other factors that could cause the actual results for Teladoc Health to differ materially from those expressed or implied in this call.

For additional information, please refer to our cautionary statement in our press release and our filings with the SEC, all of which are available on our website.

I would now like to turn the call over to Jason.

Jason Gorevic

Thank you, Patrick, and thanks everyone for joining us. This afternoon, we are pleased to report a strong third quarter with results that met or exceeded our key financial and operating guidance. Our performance reflects the fundamental strength of our business and our continued success in making better health available to our more than 90 million members.